[1] Prevention and treatment of traveler's diarrhea

[2] Fluoroquinolone safety in pediatric patients: a prospective, multicenter, comparative cohort study in France

[3] Management of nonsevere pneumonia in military trainees with the urinary antigen test for Streptococcus pneumoniae: an innovative approach to targeted therapy

[4] Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001

[5] Acute bacterial meningitis in adults: predictors of outcome

[6] Human tularemia in France, 2006-2010

[7] Bite wounds and infection

[8] Drug costs and bacterial susceptibility after implementing a single-fluoroquinolone use policy at a university hospital

[9] Impetigo: etiology and therapy

[10] Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children

[11] Polymicrobial septicemia in the cancer patient

[12] Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization

[13] Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense

[14] Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection

[15] Infection in cancer patients. A continuing association

[16] Protein binding and its significance in antibacterial therapy

[17] Postoperative toxic shock syndrome

[18] Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999

[19] Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

[20] Yersinia pestis--etiologic agent of plague

[21] Community-acquired bacterial meningitis

[22] Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study

[23] Practice guidelines for the management of bacterial meningitis

[24] The treatment of dog bite injuries, especially those of the face

[25] Does nasal colonization or mupirocin treatment affect recurrence of methicillin-resistant Staphylococcus aureus skin and skin structure infections?

[26] Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review

[27] Invasive group A streptococcal infections in Florida

[28] Persistent posttraumatic cerebrospinal fluid leakage

[29] Fever in immunocompromised patients

[30] Survival in neutropenic patients with severe sepsis or septic shock

[31] The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients

[32] Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota

[33] The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease

[34] Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria

[35] Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection

[36] Anthrax cases in pregnant and postpartum women: a systematic review

[37] Recurrent erysipelas: predisposing factors and costs of prophylaxis

[38] Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments

[39] Pathogen identification of abscesses and cellulitis

[40] Methicillin-resistant Staphylococcus aureus disease in three communities

[41] The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections

[42] Emergency management of dog and cat bite wounds

[43] A review of the clinical presentation, laboratory features, antimicrobial therapy and outcome of 77 episodes of pneumococcal meningitis occurring in children and adults

[44] The etiology of acute respiratory infections. 3. The role of viruses and bacteria

[45] Dog bite wounds and infection: a prospective clinical study

[46] High-level gentamicin resistance in Enterococcus faecalis bacteremia

[47] The etiology of bacterial cellulitis as determined by fine-needle aspiration

[48] Anthrax

[49] Office management of minor wounds

[50] Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer

[51] [Clinical guide for the evaluation and treatment of patients with neutropenia and fever]

[52] Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features

[53] Glanders in a military research microbiologist

[54] Epidemiology of human plague in the United States, 1900-2012

[55] Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure

[56] Usefulness of the Streptococcus pneumoniae urinary antigen test in the treatment of community-acquired pneumonia

[57] Clostridium difficile-associated diarrhea in HIV-infected patients: epidemiology and risk factors

[58] Management of fever in patients with cancer and treatment-induced neutropenia

[59] The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida

[60] Bacterial pyomyositis in the United States

[61] Home management of mild to moderately severe community-acquired pneumonia: a randomised controlled trial

[62] Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis

[63] BTS Guidelines for the Management of Community Acquired Pneumonia in Adults

[64] Fungemia with Saccharomycetaceae. Report of four cases and review of the literature

[65] Suboptimal aminoglycoside dosing in critically ill patients

[66] Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial

[67] Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine

[68] Emergence of multidrug-resistant Salmonella typhi in rural southern India

[69] Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997)

[70] Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study

[71] Correlation of pharmacokinetic indices with therapeutic outcome in patients receiving aminoglycosides

[72] A Lactobacillus casei Shirota probiotic drink reduces antibiotic-associated diarrhoea in patients with spinal cord injuries: a randomised controlled trial

[73] Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection

[74] Recurrent Clostridium difficile disease: epidemiology and clinical characteristics

[75] The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients

[76] Typhoid fever

[77] Typhoid fever in children: experience in King Chulalongkorn Memorial Hospital

[78] Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada

[79] Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003

[80] Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial

[81] Complications of bacteriologically confirmed typhoid fever in children

[82] Nursing home-acquired pneumonia

[83] Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review

[84] Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection

[85] Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics

[86] Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia

[87] Community-acquired pneumonia